JPH05201843A - Composition for oral cavity application - Google Patents

Composition for oral cavity application

Info

Publication number
JPH05201843A
JPH05201843A JP4014341A JP1434192A JPH05201843A JP H05201843 A JPH05201843 A JP H05201843A JP 4014341 A JP4014341 A JP 4014341A JP 1434192 A JP1434192 A JP 1434192A JP H05201843 A JPH05201843 A JP H05201843A
Authority
JP
Japan
Prior art keywords
composition
oral cavity
hexane
birch
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4014341A
Other languages
Japanese (ja)
Inventor
Minako Nomura
美奈子 野村
Yoshio Kitada
好男 北田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Chemical Industries Inc
Original Assignee
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc filed Critical Pola Chemical Industries Inc
Priority to JP4014341A priority Critical patent/JPH05201843A/en
Publication of JPH05201843A publication Critical patent/JPH05201843A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To provide a composition for oral cavity application such as candy, chewing gum, dentifrice and mouth wash effective for preventing dental caries and periodontosis. CONSTITUTION:The objective composition contains 0.01-1.0wt.%, preferably 0.05-0.5wt.% (in terms of dry solid) of an extract extracted from birch known as a crude herb drug by conventional extraction method. The extraction solvent is e.g. a low-polarity solvent such as hexane and ether, a high-polarity solvent such as acetone, ethyl acetate, ethanol and water or their mixture. The use of a low-polarity solvent such as hexane and ether is preferable from the viewpoint of antibacterial property.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は齲(う)蝕及び歯周病の
予防に有効なキャンデー、ガム、歯磨き、口中洗浄剤な
どの口腔用組成物に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an oral composition such as candy, gum, toothpaste and mouthwash which is effective in preventing dental caries and periodontal disease.

【0002】[0002]

【従来の技術】近年、う蝕及び歯周病の原因についての
微生物学的成果として、これら口腔歯科領域の二大疾患
は、いずれも口腔内細菌が引金となって発生することが
明かとなった。すなわち、口腔内微生物、特にストレプ
トコッカス・ミュータンス(Streptococcus mutans、以
下S.ミュータンスという。)の菌体外酵素であるグル
コシルトランスフェラーゼ(以下GTaseという。)
によって食物中のショ糖が粘着性を有する多糖類(グル
カン)に変換され、このグルカンが歯面に付着して菌体
の凝集塊、すなわち歯垢を形成する。この歯垢中で微生
物(乳酸菌やグラム陰性菌)が繁殖し、更にこれらの微
生物の解糖系により、乳酸などの有機酸が醗酵生産され
る。
2. Description of the Related Art In recent years, as microbiological results regarding the causes of dental caries and periodontal disease, it has been clarified that these two major diseases in the oral and dental fields are caused by oral bacteria. became. That is, glucosyltransferase (hereinafter referred to as GTase), which is an extracellular enzyme of oral microorganisms, particularly Streptococcus mutans (hereinafter referred to as S. mutans).
By this, sucrose in the food is converted into a sticky polysaccharide (glucan), and this glucan adheres to the tooth surface to form an aggregate of bacterial cells, that is, plaque. Microorganisms (lactic acid bacteria and gram-negative bacteria) propagate in the dental plaque, and the glycolytic system of these microorganisms further fermentatively produces organic acids such as lactic acid.

【0003】この有機酸により歯面のpHが低下する
と、この酸によって歯牙の脱灰が起こり、う蝕が誘発さ
れると共に、グラム陰性菌の毒素によって歯周病が発生
することになる。従って、このう蝕や歯周病の発生を予
防するには、S.ミュータンスの活動を停止させるのが
最も効果的である。すなわち、S.ミュータンスの活動
が停止すれば、GTaseの産生、ひいては粘着性グル
カンの生成が阻止され、当然プラークも発生しない。
When the pH of the tooth surface is lowered by this organic acid, the acid causes demineralization of teeth, induces dental caries, and causes toxins of Gram-negative bacteria to cause periodontal disease. Therefore, in order to prevent the occurrence of this dental caries and periodontal disease, S. It is most effective to stop the activity of mutans. That is, S. When the activity of mutans is stopped, the production of GTase, and thus the production of sticky glucan, is blocked, and naturally plaque does not occur.

【0004】従来より、このS.ミュータンスの活動を
抑える目的で種々の殺菌剤や抗生物質が使用されてきた
が、それぞれ欠点を有しており、必ずしも満足すべき結
果が得られていない。例えば、抗生物質は長期連用には
不向きであるし、クロルヘキシジンなどの殺菌剤は毒性
が強い上、歯牙や舌を着色するという欠点を有する。更
に、一般に抗生物質や殺菌剤は口腔内の正常な細菌を殺
してしまうため、正常な細菌叢が変化して真菌などの異
常繁殖を招来し、生体にとって好ましくない状況を呈す
ることが多い。
Conventionally, the S. Various fungicides and antibiotics have been used for the purpose of suppressing the activity of mutans, but they have their respective drawbacks, and the satisfactory results are not always obtained. For example, antibiotics are not suitable for long-term continuous use, and bactericides such as chlorhexidine are highly toxic and have the drawback of coloring teeth and tongue. Furthermore, since antibiotics and bactericides generally kill normal bacteria in the oral cavity, the normal bacterial flora is changed to cause abnormal growth of fungi and the like, often resulting in an unfavorable situation for the living body.

【0005】[0005]

【発明が解決しようとする課題】本発明の課題は、従来
技術における以上のような欠点を除去し、毒性がなく、
しかも口腔内の正常な細菌を殺すことなく、う蝕や歯周
病の発生を予防し得る口腔用組成物を提供することであ
る。
The object of the present invention is to eliminate the above-mentioned drawbacks in the prior art, to be non-toxic,
Moreover, it is to provide an oral composition capable of preventing the occurrence of dental caries and periodontal disease without killing normal bacteria in the oral cavity.

【0006】[0006]

【課題を解決するための手段】本発明者らはS.ミュー
タンスに対し高い抗菌作用を有する有効成分を得るため
に 、種々の植物有効成分についてスクリーニングによ
る研究を行った結果、ある種のハーブ生薬抽出物がS.
ミュータンスに対し高い抗菌作用を有することを見いだ
し、本発明に到達した。
The present inventors have found that S. In order to obtain an active ingredient having a high antibacterial activity against mutans, as a result of a screening study on various plant active ingredients, a certain herbal crude drug extract was identified as S.
The inventors have found that they have a high antibacterial action against mutans and have reached the present invention.

【0007】即ち、本発明の口腔用組成物はバーチ抽出
物を有効成分として含有することを特徴とするものであ
る。以下、本発明を詳細に説明する。
That is, the oral composition of the present invention is characterized by containing a birch extract as an active ingredient. Hereinafter, the present invention will be described in detail.

【0008】本発明で使用されるバーチ抽出物は、ハー
ブ生薬として知られるバーチから公知の方法に従って抽
出された抽出物であって、液状(抽出液のまま、或は希
釈液または濃縮エキスとして)であっても、ペースト状
であっても、或は粉末状であってもよい。
The birch extract used in the present invention is an extract extracted from birch known as an herbal crude drug according to a known method, and is a liquid (as an extract, or as a diluent or concentrated extract). It may be in the form of paste, or powder.

【0009】この場合の抽出溶媒としては、ヘキサン、
エーテルなどの低極性溶媒、アセトン、酢酸エチル、エ
タノール、メタノール、水などの極性溶媒、及びそれら
の混合物が挙げられるが、抗菌性の点からヘキサン、エ
ーテルなどの低極性溶媒が好ましい。抽出方法としては
常法、すなわち、抽出溶媒中で加熱還流するか、加温、
常温または冷却下に浸漬する等の方法が採用される。な
お、水抽出液の場合は、そのまま、あるいは適当に希釈
して使用することもできるが、濃縮、凍結乾燥等によっ
て粉末或はペースト状とした後、適当な口腔用組成物の
形に製剤化して使用するのが好ましい。
In this case, the extraction solvent is hexane,
Examples include low polar solvents such as ether, polar solvents such as acetone, ethyl acetate, ethanol, methanol and water, and mixtures thereof, but low polar solvents such as hexane and ether are preferable from the viewpoint of antibacterial properties. The extraction method is a conventional method, that is, heating under reflux in an extraction solvent, or heating,
A method such as immersion at room temperature or under cooling is adopted. In the case of a water extract, it can be used as it is or after being appropriately diluted, but it is made into a powder or paste by concentration, freeze-drying, etc., and then formulated into a suitable oral composition. Is preferably used.

【0010】以下にバーチ抽出物の製造例を示す。 <製造例1>バーチ乾燥末100gに約1000mlの
ヘキサンを加え、3時間加熱還流、抽出する。抽出液を
濾過した後、エバポレーターを用いて溶媒を留去するこ
とにより、約1.2gのバーチ抽出物が得られた。
The production example of the birch extract is shown below. <Production Example 1> About 1000 ml of hexane is added to 100 g of dried birch powder, and the mixture is heated under reflux for 3 hours for extraction. After filtering the extract, the solvent was distilled off using an evaporator to obtain about 1.2 g of a birch extract.

【0011】<製造例2>ヘキサンの代わりにメタノー
ルを用いた他は、製造例1と同様の操作を行い、約1
0.6gのバーチ抽出物を得た。
<Production Example 2> The procedure of Production Example 1 was repeated except that methanol was used in place of hexane to obtain about 1
0.6 g of birch extract was obtained.

【0012】前記バーチ抽出物の含有量は組成物全量に
対して乾燥固形分で通常0.01〜1.0重量%、好ま
しくは0.05〜0.5重量%の範囲である。なお、
0.01%未満ではう蝕や歯周病の予防効果が少なく、
また1.0%を越えても増量に見合った効果の増加が期
待できない場合がある。
[0012] The content of the birch extract is usually 0.01 to 1.0% by weight, preferably 0.05 to 0.5% by weight, based on the total amount of the composition as a dry solid content. In addition,
If it is less than 0.01%, the preventive effect against caries and periodontal disease is small,
Further, even if it exceeds 1.0%, it may not be possible to expect an increase in the effect commensurate with the increase in the amount.

【0013】本発明の組成物にはその他の成分として、
通常の口腔用組成物に用いられるものを使用することが
できる。例えば、キャンディーには、50〜90%の砂
糖、10〜50%の水飴、0〜3%の酸、0.05〜1
%の香料等を、ガムには、10〜30%のガムベース
(植物性樹脂、酢酸ビニル樹脂、エステルガム等)、5
0〜85%の砂糖、3〜10%の水飴、その他適量の香
料、軟化剤を、歯磨きには、20〜90%の研磨剤(リ
ン酸水素カルシウム、炭酸カルシウム等)、10〜40
%の湿潤剤(グリセリン、ソルビット等)、0.5〜2
%の界面活性剤(ラウリル硫酸エステル塩等)、0.0
5〜0.2%の甘味料、0.5〜1.5%の香料、0.
2〜1.5%の増粘剤(カルボキシメチルセルロース、
アルギン酸ナトリウム、カラギーナン、メチルセルロー
ス等)を配合することができる。
Other components of the composition of the present invention include
What is used for the usual composition for oral cavity can be used. For example, for candy, 50-90% sugar, 10-50% starch syrup, 0-3% acid, 0.05-1
% Gum, 10-30% gum base (vegetable resin, vinyl acetate resin, ester gum, etc.), 5%
0-85% sugar, 3-10% starch syrup, other appropriate amount of fragrance, softener, toothpaste 20-90% abrasive (calcium hydrogen phosphate, calcium carbonate, etc.), 10-40
% Wetting agent (glycerin, sorbit, etc.), 0.5-2
% Surfactant (such as lauryl sulfate salt), 0.0
5-0.2% sweetener, 0.5-1.5% flavor, 0.
2 to 1.5% thickener (carboxymethyl cellulose,
Sodium alginate, carrageenan, methyl cellulose, etc.) can be added.

【0014】本発明の口腔用組成物にはその他、う蝕や
歯周病の予防効果を更に向上するためにクロルヘキシジ
ン、ベンザルコニウム等の殺菌剤を添加したり、あるい
は保存剤、香料、着色剤等を添加することができる。
To the oral composition of the present invention, in addition, a bactericide such as chlorhexidine or benzalkonium is added in order to further improve the preventive effect against dental caries or periodontal disease, or a preservative, a fragrance or a coloring agent is added. Agents and the like can be added.

【0015】本発明の口腔用組成物の剤型は液剤、固形
剤、半固形剤のいずれであってもよく、具体的には歯磨
き剤、トローチ剤、液状または粉末状うがい薬、塗布
液、チュウインガムなどの形で使用できる。
The dosage form of the composition for oral cavity of the present invention may be any of liquid, solid and semi-solid preparations, specifically, dentifrice, troche, liquid or powder mouthwash, coating liquid, It can be used in the form of chewing gum.

【0016】[0016]

【作用】本発明の組成物に用いられるバーチ抽出物の抗
菌作用を知るために、下記のような試験を行った。
In order to know the antibacterial action of the birch extract used in the composition of the present invention, the following test was conducted.

【0017】<試験例(抗菌活性の測定)> (試験方法)試験管に9.9mlのブレインハートイン
フュージョン(BHI)液体培地を加え、ついで10m
gのサンプルあるいは対照としてローズマリー、カミツ
レ、ウスベニアオイの抽出物を加え、分散し、予め前培
養した下記の菌株の培養液100μlを加え、37℃で
嫌気培養した。24時間放置した後、TSA(トリプト
ソイ寒天)培地にプレーティングし、生菌数を測定し
た。 試験に用いた菌株: 1.ストレプトコッカス・ミュータンス(Streptococcus
mutans) IFO-13955 2.バチルス・ズブチリス(Bacillus subtilis) IFO-13
721 3.スタフィロコッカス・アウレウス(Staphylococcus
aureus) IFO-12732 4.エシェリシア・コリ(Escherichia coli) IFO-3972 5.シュードモナス アエルギノーサ(Pseudomonas aer
uginosa) IFO-13275 上記に示す1〜5の菌株を生理食塩水に懸濁し、初発菌
数が1×106個/mlになるように濁度調整した原液
100μlを菌液とする。各種菌株に対する抗菌活性
(生菌数の測定結果)を下記表1に示す。
<Test Example (Measurement of Antibacterial Activity)> (Test Method) 9.9 ml of Brain Heart Infusion (BHI) liquid medium was added to a test tube, and then 10 m.
As a sample of g or a control, extracts of rosemary, chamomile, and mung bean were added, dispersed, and 100 μl of a culture solution of the following strain pre-cultured beforehand was added, followed by anaerobic culture at 37 ° C. After leaving it for 24 hours, it was plated on TSA (tryptosoy agar) medium and the viable cell count was measured. Strains used in the test: 1. Streptococcus mutans
mutans) IFO-13955 2. Bacillus subtilis IFO-13
721 3. Staphylococcus
aureus) IFO-12732 4. Escherichia coli IFO-3972 5. Pseudomonas aeruginosa
uginosa) IFO-13275 The bacterial strains 1 to 5 shown above are suspended in physiological saline, and 100 μl of a stock solution having a turbidity adjusted so that the initial number of bacteria is 1 × 10 6 cells / ml is used as a bacterial solution. The antibacterial activity against various strains (measurement result of viable cell count) is shown in Table 1 below.

【0018】[0018]

【表1】 [Table 1]

【0019】(評価結果) 1.う蝕及び歯周病を引き起こすS.ミュータンスに対
して選択的に抗菌活性を示し、他の菌に対しては悪影響
を及ぼさない。 2.溶媒の種類については、低極性溶媒を用いて抽出し
たものが抗菌活性が高い。 3.他のハーブ生薬の抽出物は抗菌活性を示さないのに
対し、バーチの抽出物は顕著な抗菌活性を有している。
(Evaluation result) 1. S. causing caries and periodontal disease It selectively shows antibacterial activity against mutans and has no adverse effect on other bacteria. 2. Regarding the type of solvent, those extracted using a low polar solvent have high antibacterial activity. 3. Extracts of other herbal crude drugs do not show antibacterial activity, whereas extracts of birch have remarkable antibacterial activity.

【0020】[0020]

【実施例】以下に本発明の口腔用組成物を実施例によっ
て説明する。なお、実施例中の配合割合(部)は全て重
量部である。
[Examples] The oral composition of the present invention will be described below with reference to Examples. The mixing ratios (parts) in the examples are all parts by weight.

【0021】[0021]

【実施例1】(キャンデー) 表2の成分を混合し、キャンデー組成物を製造した。な
お、使用したバーチ抽出物は製造例1と同様にして製造
したものである。
Example 1 (Candy) The components shown in Table 2 were mixed to produce a candy composition. The birch extract used was produced in the same manner as in Production Example 1.

【0022】[0022]

【表2】 [Table 2]

【0023】[0023]

【実施例2】表3の成分を混合し、歯磨き組成物を製造
した。なお、使用したバーチ抽出物は製造例1と同様に
して製造したものである。
Example 2 A toothpaste composition was prepared by mixing the ingredients shown in Table 3. The birch extract used was produced in the same manner as in Production Example 1.

【0024】[0024]

【表3】 [Table 3]

【0025】[0025]

【実施例3】(キャンデー) 表4の成分を混合し、キャンデー組成物を製造した。な
お、使用したバーチ抽出物は、製造例1と同様にして製
造したものである。
Example 3 (Candy) A candy composition was prepared by mixing the ingredients shown in Table 4. The birch extract used was produced in the same manner as in Production Example 1.

【0026】[0026]

【表4】 [Table 4]

【0027】[0027]

【実施例4】(歯磨き) 表5の成分を混合し、歯磨き組成物を製造した。なお、
使用したバーチ抽出物は、製造例1と同様にして製造し
たものである。
Example 4 (Toothpaste) The ingredients shown in Table 5 were mixed to produce a toothpaste composition. In addition,
The birch extract used was produced in the same manner as in Production Example 1.

【0028】[0028]

【表5】 [Table 5]

【0029】[0029]

【発明の効果】本発明の口腔用組成物は、以上のような
抗菌活性を有するバーチ抽出物を含むので、う蝕及び歯
周病の予防に有効な抗菌作用のあるキャンデー、ガム、
歯磨き、口中洗浄剤等として利用することができる。
Since the oral composition of the present invention contains the birch extract having the above-mentioned antibacterial activity, it can effectively prevent cavities and periodontal diseases.
It can be used as toothpaste, mouthwash, etc.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 バーチ抽出物を含有することを特徴とす
る口腔用組成物。
1. An oral composition comprising a birch extract.
【請求項2】 バーチ抽出物の含有量が0.01〜1重
量%である請求項1記載の口腔用組成物。
2. The oral composition according to claim 1, wherein the content of the birch extract is 0.01 to 1% by weight.
JP4014341A 1992-01-29 1992-01-29 Composition for oral cavity application Pending JPH05201843A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4014341A JPH05201843A (en) 1992-01-29 1992-01-29 Composition for oral cavity application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4014341A JPH05201843A (en) 1992-01-29 1992-01-29 Composition for oral cavity application

Publications (1)

Publication Number Publication Date
JPH05201843A true JPH05201843A (en) 1993-08-10

Family

ID=11858370

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4014341A Pending JPH05201843A (en) 1992-01-29 1992-01-29 Composition for oral cavity application

Country Status (1)

Country Link
JP (1) JPH05201843A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6280778B1 (en) * 1998-11-02 2001-08-28 Daniel Gaudet Process for preparing natural product derivatives from plants in a single step
JP2022093452A (en) * 2018-06-25 2022-06-23 ロート製薬株式会社 Oral composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6280778B1 (en) * 1998-11-02 2001-08-28 Daniel Gaudet Process for preparing natural product derivatives from plants in a single step
JP2022093452A (en) * 2018-06-25 2022-06-23 ロート製薬株式会社 Oral composition

Similar Documents

Publication Publication Date Title
JP4201898B2 (en) Antibacterial preparation
DE10394357T5 (en) Oro-dental herbal care composition and method of making the same
JP3241955B2 (en) Oral composition
JP3614479B2 (en) Periodontal disease-causing bacteria or caries-causing bacteria inhibitor, oral composition and food containing them
JPH0232255B2 (en)
JP5705537B2 (en) Composition comprising the use of an aqueous grape seed extract in combination with at least one fluoride salt and combinations thereof to address the formation or accumulation of dental biofilms
JP2848688B2 (en) Oral composition
JPH03240721A (en) Composition for oral cavity
CN109908072B (en) Marine organism polysaccharide toothpaste containing probiotics and preparation method thereof
JP7445910B2 (en) Oral compositions, oral care products, and foods containing oral resident bacteria regulators
JPWO2019208699A1 (en) Oral flora improver and oral composition
JP3009531B2 (en) Periodontal disease prevention agent
JPH05201843A (en) Composition for oral cavity application
CN108078849A (en) A kind of gargle containing chitosan and preparation method thereof
JPH0639375B2 (en) Anti-caries agent
JP2986991B2 (en) Oral composition
JP2723551B2 (en) Oral composition
JPH08231361A (en) Composition for oral cavity
JP6918359B2 (en) Deodorant composition for axillary odor
JPS61268613A (en) Composition for oral cavity containing evening primrose seed oil
JP7393823B2 (en) Oral composition for periodontal disease bacteria
JP4515732B2 (en) Glucosyltransferase inhibitors, plaque formation inhibitors, antibacterial agents, oral preparations and foods for preventing touch
JP3022047B2 (en) Oral composition
KR102540804B1 (en) Composition containing Torreya nucifera extracts for preventing the formation of biofilm of mmicroorgaism
JP3346083B2 (en) Antibacterial agent and oral composition